DSGN

NASDAQStock

Design Therapeutics, Inc.

$10.02-0.01 (-0.05%)

52-Week Range

$2.79

$10.97

Key Stats

Market Cap

570.5M

P/E Ratio

—

Dividend Yield

—

Beta

1.63

Volume

269.8K

Avg Volume

191.9K

Performance

-0.50%

+9.87%

+71.28%

YTD

+10.11%

+103.25%

+42.53%

-75.85%

Price Chart

ETF Exposure

DSGN is held by 54 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VTHR	Vanguard Russell 3000 ETF	0.00%	2,331	$24K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	984,775	$10.1M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	5,179	$72K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	446	$6K	$1.29B	0.17%

PreviousPage 2 of 2

About DSGN ETF Exposure

Design Therapeutics, Inc. (DSGN) is held by 54 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 570.5M, DSGN is a widely held institutional stock. The stock currently trades at $10.02. Investors can gain exposure to DSGN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold DSGN, sorted by portfolio weight.